PRNewswire

BEIJING, April 29, 2024 /PRNewswire/ -- Recently, at Auto China 2024, Neusoft Corporation (Neusoft, SSE:600718) launched OneCoreGo® Global In-Vehicle Intelligent Mobility Solutions 5.0, showcasing its innovative achievements in the AI+ Automotive field. It's also one of the series of products developed under Neusoft's intelligent solution strategy.

Since the 1990s, Neusoft has provided an extensive array of navigation products to the global market. The newly... (continue reading...)

• Revenue Reached RMB7,982 Million; Excluding COVID-19 Commercial Projects, Down 1.8%
• Net Profit Attributable to the Owners of the Company Reached RMB1,942 Million; Diluted Earnings per Share (EPS) Reached RMB0.66
• Adjusted Non-IFRS Net Profit Attributable to the Owners of the Company Reached RMB1,913 Million; Adjusted Non-IFRS Diluted EPS Reached RMB0.65[1]
• Free Cash Flow Remained Positive and Reached RMB1,326 Million

SHANGHAI, April 29, 2024 /PRNewswire/ -- WuXi AppTec... (continue reading...)

-  Gerresheimer subsidiary Centor receives exclusive distribution rights for pharmacies in the U.S.

-  Adherence solutions enables pharmacies to offer remote therapeutic monitoring

-  Digital therapy support leads to improved health outcomes

-   Picture is available at AP -

DÜSSELDORF, Germany and BERLIN, Ohio, April 29, 2024 /PRNewswire/ -- Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics... (continue reading...)

SHANGHAI, April 29, 2024 /PRNewswire/ -- /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2024, before U.S. markets open on May 13, 2024.

The Company will hold an earnings conference call at 8:00 A.M. Eastern Time on Monday, May 13,... (continue reading...)

Assay expands company's leadership in precision medicine and cell and gene therapy

BURLINGTON, N.C., April 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the U.S. Food and Drug Administration (FDA) has approved its nAbCyte™ Anti-AAVRh74var HB-FE Assay, a companion diagnostic (CDx) to determine patient eligibility for treatment with BEQVEZ™ (fidanacogene elaparvovec-dzkt),... (continue reading...)